SEC Form 4 · accession 0001209191-17-037242
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Margaret Faye Wilson
Director
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.50 | May 31, 2017 | A | 15,000 | A | — | May 30, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The shares subject to the option shall be 100% vested and exercisable on May 2, 2018.